Skip to main content
Log in

Indications for routine heart-catheterization after CABG and PTCA

  • Published:
The International Journal of Cardiac Imaging Aims and scope Submit manuscript

Abstract

Routine heart-catheterization after Coronary Artery Bypass Graft surgery (CABG) or Percutaneous Transluminal Coronary Angioplasty (PTCA) has been advocated to determine the change in bypass graft or dilated coronary artery and native coronary artery status, the effective disease remaining after CABG or PTCA and the relation between progression of disease, left ventricular function and symptomatology. Results of angiographic follow-up data after CABG and PTCA are presented and the practical implications are discussed. The reliability of symptoms, invasive and non-invasive test for the detection of ischemia are considered. Finally, recommendations are made for the indication of routine heart-catheterization after CABG and PTCA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Laarman G, Luiten HE, van Zeyl LGPM, Beatt KJ, Tijssen JGP, Serruys PW, de Feyter PJ. Assessment of ‘Silent’ restenosis and long term follow-up after successful angioplasty in single vessel coronary artery disease: The value of quantitative exercise electrocardiography and quantitive coronary angiography. J Am Coll Cardiol 1990; 16: 578–85.

    Google Scholar 

  2. Brower RW, Laird-Meeter K, Serruys PW, Meester GT, Hugenholtz PG. Long term follow-up after coronary artery bypass graft surgery. Progression and regression of disease in native coronary circulation and bypass grafts. Br Heart J 1983; 50: 42–7.

    Google Scholar 

  3. Loop FD, Lytle BW, Cosgrove DM et al. Influence of the internal mammary artery graft on 10-year survival and other cardiac events. N Engl J Med 1986; 314: 1–6.

    Google Scholar 

  4. Bourassa MG, Fisher LD, Campeau L, Gillespie MJ, McConney M, Lesperance J. Long-term fate of bypass grafts: The Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Circulation 1985; 72(V): 71–8.

    Google Scholar 

  5. Sergeant P, Lesaffre E, Flameng W, Suy R, Blackstone E. The return of clinically evident ischemia after coronary artery bypass grafting. Eur J Cardio-Thorac Surg 1991; 5: 1–12.

    Google Scholar 

  6. Sergeant P, Lesaffre E, Flameng W, Suy R. Internal mammary artery: Methods of use and their effect on survival after coronary bypass surgery. Eur J Cardio-Thorac Surg 1990; 4: 72–8.

    Google Scholar 

  7. Simonton CA, Mark DB, Hinohara T, Rendall DS, Phillips HR III, Peter RH, Behar VS, Kong Y, O'Callaghan WG, O'Connor CM et al. Late restenosis after emergent coronary angioplasty for acute myocardial infarction: Comparison with elective coronary angioplasty. J Am Coll Cardiol 1988; 11: 698–705.

    Google Scholar 

  8. Califf RM, Ohram EM, Frid DJ et al. Restenosis: The clinical issues. In: Topol EJ (ed.) Textbook of interventional cardiology. Philadelphia, London, Toronto, Montreal, Sydney, Tokyo: W.B. Saunders Company Heartcourt Brace Jovanovick, Inc., 1990: 363–94.

    Google Scholar 

  9. Zardi AR, Hollman J, Galan K, Belardi J, Franco I, Simpfendorfer CC. Predictive value of chest discomfort for restenosis following successful coronary angioplasty. Circulation 1985; 72 (suppl III): 456.

    Google Scholar 

  10. Mabin TA, Holmes DR Jr, Smith HC, Vliestra RE, Reeder GS, Breshahan JF, Bove AA, Hammes LN, Elveback LR, Orszulak TA. Follow-up clinical results in patients undergoing percutaneous transluminal coronary angioplasty. Circulation 1985; 71: 754–60.

    Google Scholar 

  11. Levine S, Ewels CJ, Rosing DR, Kent KM. Coronary angioplasty: Clinical and angiographie follow-up. Am J Cardiol 1985; 55: 673–6.

    Google Scholar 

  12. Jutzy KR, Berte LE, Alderman EL, Ratts J, Simpson JB. Coronary restenosis rates in consecutive patient series one year post successful angioplasty (abstract). Circulation 1982; 66 (suppl II): II-331.

    Google Scholar 

  13. Gruentzig AR, King III SB, Schlumpf M, Siegenthaler W. Long-term follow-up after percutaneous transluminal coronary angioplasty. N Eng J Med 1987; 316: 1127–32.

    Google Scholar 

  14. Bengston JR, Mark DB, Honan MB, Rendall DS, Hinohara T, Stack RS, Hlatky MA, Califf RM, Lee KL, Pryor DB. Detection of restenosis after elective percutaneous transluminal coronary angioplasty using the exercise treadmill test. Am J Cardiol 1990; 65: 28–34.

    Google Scholar 

  15. Renkin J, Melin J, Robert A, Richelle F, Bachly JL, Col J, Detry JM, Wijns W. Detection of restenosis after successful coronary angioplasty: Improved clinical decision making with the use of a logistic model combining procedural and follow-up variables. J Am Coll Cardiol 1990; 16: 1333–40.

    Google Scholar 

  16. O'Keefe JH, Lapeyre AC, Holmes DR, Gibbons RJ. Usefulness of early radionuclide angiography for identifying low-risk patients for late restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1988: 61: 51–4.

    Google Scholar 

  17. Scholl JM, Chaitman BR, David PR, Dupras G, Brevers G, Val PG, Crepeau J, Lesperance J, Bourassa MG. Exercise electrocardiography and myocardial scintigraphy in the serial evaluation of the results of percutaneous transluminal coronary angioplasty. Circulation 1982; 66: 380–90.

    Google Scholar 

  18. Wijns W, Serruys PW, Simoons ML, van den Brand M, de Feyter PJ, Reiber JH, Hugenholtz PG. Predictive value of early maximal exercise test and thallium scintigraphy after successful percutaneous transluminal coronary angioplasty. Br Heart J 1985; 53: 194–200.

    Google Scholar 

  19. Wijns W, Serruys PW, Reiber JHC, de Feyter PJ, van den Brand M, Simoons ML, Hugenholtz PG, Tijssen JGP. Early detection of restenosis after successful percutaneous transluminal coronary angioplasty by exercise-redistribution thallium scintigraphy. Am J Cardiol 1985; 55: 357–61.

    Google Scholar 

  20. Rosing DR, Van Raden JM, Mincemoyer RM, Bonow RO, Bourassa MG, David PR, Ewels CJ, Detre KM, Kent KM. Exercise electrocardiographic and functional responses after percutaneous transluminal coronary angioplasty. Am J Cardiol 1984; 53: 36C-41C.

    Google Scholar 

  21. Ernst SM, Hillebrand FA, Klein B, Ascoop CA, van Tellingen C, Plokker HW. The value of exercise tests in the follow-up of patients who underwent transluminal coronary angioplasty. Int J Cardiol 1985; 7: 267–79.

    Google Scholar 

  22. Honan MB, Bengtson JR, Rendall DS, Pryor DB, Hinohara T, Stack RS, Califf RM, Hlatky MA, Mark DB. Exercise tests cannot identify patients with angiopgraphic restenosis after angioplasty for myocardial infraction (abstract). Circulation 1988; 78 (suppl II): 112.

    Google Scholar 

  23. Lefkowitz CA, Ross BL, Schwartz L et al. Superiority of tomographic thallium imaging for the detection of restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1988; 13: 161A.

    Google Scholar 

  24. Jain A, Mahmarian JJ, Borges-Neto S, Johnston DL, Lewis JM, Raizner AE, Verani MS. Clinical significance of perfusion defects by thallium-201 single photon emission tomography following oral dipyridamole early after coronary angioplasty. J Am Coll Cardiol 1988; 11: 970–6.

    Google Scholar 

  25. Miller DD, Liu P, Strauss HW, Block PC, Okada RD, Boucher CA. Prognostic value of computer-quantified exercise thallium imaging early after percutaneous transluminal coronary agnioplasty. J Am Coll Cardiol 1987; 10(2): 275–83.

    Google Scholar 

  26. Lam JYT, Chaitman BR, Byers S, Bowles J, Wiens RD, Goodgold H, Samuels L. Can dipyridamole thallium imaging predict restenosis after coronary angioplasty? Circulation 1987; 76 (suppl IV): 373.

    Google Scholar 

  27. Mercator Study Group. Does the new angiotensine converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the Mercator study: A multicenter, randomized, double blind placebo controlled trial. Circulation 1992; 86: 100–10.

    Google Scholar 

  28. Serruys PW, Rutch W, Hendrickx GR, Danchin N, Mast EG, Wijns W, Rensing BJ, Vos J, Stibbe J. Prevention of restenosis after percutaneous transluminal coronary angioplasty with tromboxane A2-receptor blockade: A randomized, double blind, placebo controlled trial. Circulation 1991; 84: 1568–80.

    Google Scholar 

  29. Ornish D, Brown SE, Scherwitz LW et al. Can life style change reverse coronary heart disease? The Lancet 1990; 336: 129–33.

    Google Scholar 

  30. Frasure-Smith N, Prince R. The ischaemic heart disease life stress monitoring program: Impact on mortality. Psychosom Med 1985; 47: 431–45.

    Google Scholar 

  31. Magometschnigg H, Kadletz M, Vodrazka M, Dock W, Grimm M, Grabenwoger M, Minar E, Straudacher M, Fenzl G, Wolner E. Prospective clinical study within vitro endothelial cell lining of expanded polytetrafluorethylene grafts in crural repeat reconstruction. J Vasc Surg 1992; 15: 527–35.

    Google Scholar 

  32. Nishibe T. Study on patency of small caliber synthetic vascular prosthesis with special reference to antitrombogenesity of fibrin layer. Hokkaido Igaku Zasshi 1991; 66: 758–67.

    Google Scholar 

  33. Serruys PW, Breeman A. Coronary angioplasty, clinical application 1991. Neth J Cardiol 1991; 4: 146–54.

    Google Scholar 

  34. Topol E. Promises and pitfalls of new devices for coronary artery disease. Circulation 1991; 83: 689–94.

    Google Scholar 

  35. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB III Loop FD et al. Guidelines for percutaneous transluminal coronary angioplasty. Circulation 1988; 78: 486–502.

    Google Scholar 

  36. Tommaso CL, Vogel JH, Vogel RA. Coronary angioplasty in high-risk patients with left main coronary stenosis: Results from the National Registry of Elective Supported Angioplasty. Cathet-Cardiovasc-Diagn 1992; 25: 169–73.

    Google Scholar 

  37. Samson M, Plante S, Meester H, Rensing JB, de Feyter PJ, Serruys PW. Left main coronary angioplasty: Assessment of a ‘risk score’ to predict acute and long-term outcome. J Interven Cardiol 1990; 3: 75–85.

    Google Scholar 

  38. Gao S, Alderman EL, Schroeder JS, Silverman JF, Hunt SA. Accelerated coronary vascular disease in the heart transplant patient: Coronary arteriographie findings. JACC 1988; 12: 334–40.

    Google Scholar 

  39. Bieber C, Stinson EB, Shumway NE, Payne R, Kosek J. Cardiac transplantation in man. VII. Cardiac allograft pathology. Circulation 1970; 11: 753–72.

    Google Scholar 

  40. Reid JM, Dargie HJ, Risk stratification after myocardial infarction with and without coronary artery bypass grafting. Eur Heart J 1988; 9: 91–100.

    Google Scholar 

  41. Shiu MF. Percutanous transluminal coronary angioplasty and flying status. Eur Heart J 1988; 9: 101–5.

    Google Scholar 

  42. Serruys PW, Breeman A. Coronary angioplasty. Long term follow-up results and detection of restenosis: Guidelines for aviation cardiology. A European View. Eur Heart J 1992. In press.

  43. Ivanhoe RJ, Weintraub WS, Douglas JS, Lenbo JS, Furman M, Gershony G, Cohen CL, King SB II. Percutaneous transluminal coronary angioplasty of chronic total occlusion (primary success, restenosis and long term clinical follow-up). Circulation 1992; 85: 106–15.

    Google Scholar 

  44. Safian RD, Cabe MC, Sipperly ME, McKay RG, Bairn DS. Initial success and long term follow-up of percutaneous transluminal coronary angioplasty in chronic total occlusions versus conventional stenosis. Am J Cardiol 1988; 61: 23G-8G.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Breeman, A., Serruys, P.W. Indications for routine heart-catheterization after CABG and PTCA. Int J Cardiac Imag 9 (Suppl 1), 71–76 (1993). https://doi.org/10.1007/BF01143148

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01143148

Key words

Navigation